Sirtuin Type 1 Mediates the Antidepressant Effect of S-Ketamine in a Chronic Unpredictable Stress Model
Authors:
Open Access
- 19 May 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 13, 855810
Abstract
Background: Major depressive disorder (MDD) refers to a mental disease with complex pathogenesis and treatment mechanism. S-ketamine exhibited high effectiveness in treating MDD. However, the pharmacological activity of S-ketamine has not been reported yet.Materials and Methods: In this study, depression-like characteristics were induced by chronic unpredictable stress (CUS). After S-ketamine (15 mg/kg) was intraperitoneally injected, the behaviors of mice were tested by conducting open-field test, elevated plus maze test, tail suspension test, and forced swimming test. Bilateral injection of sirtuin type 1 (SIRT1) inhibitor EX-527 was injected into the medial prefrontal cortex (mPFC) to upregulate the SIRT1 expression. The expression of SIRT1 and brain-derived neurotrophic factor (BDNF) was detected by conducting Western blot and immunofluorescence assays. Meanwhile, the synaptic ultrastructure was detected by transmission electron microscopy.Results: In this study, the mice showed depression-like behavior in a series of behavioral tests. After the treatment with S-ketamine, the depression-like behavior stopped. Further, the synaptic ultrastructure in mPFC, including the decreased curvature of the post synaptic density and thinning of the postsynaptic density, improved after the S-ketamine treatment. Moreover, we found that S-ketamine had the possibility of spontaneous binding with SIRT1 at the molecular level and reversed CUS-induced SIRT1 reduction. Meanwhile, a positive relationship between SIRT1 and BDNF expression in mPFC and SIRT1 inhibitor limited the role of S-ketamine in reducing the depression-like behavior and increasing the BDNF level.Conclusion: S-ketamine upregulated the SIRT1-mediated BDNF in mPFC and reversed the synaptic structural defects caused by CUS. SIRT1 is a mediator of S-ketamine in alleviating depression-like behavior.Keywords
This publication has 44 references indexed in Scilit:
- The effects of chronic stress on hippocampal adult neurogenesis and dendritic plasticity are reversed by selective MAO-A inhibitionJournal of Psychopharmacology, 2014
- Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTORPsychopharmacology, 2013
- Altered sirtuin deacetylase gene expression in patients with a mood disorderJournal of Psychiatric Research, 2011
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responsesNature, 2011
- SIRT1 gene is associated with major depressive disorder in the Japanese populationJournal of Affective Disorders, 2010
- A novel pathway regulates memory and plasticity via SIRT1 and miR-134Nature, 2010
- Brain-derived neurotrophic factor gene and protein expression in pediatric and adult depressed subjectsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2010
- Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMSNeuropsychobiology, 2005
- Increase in postsynaptic density material in optic target neurons of the rat suprachiasmatic nucleus after bilateral enucleationNeuroscience Letters, 1980
- An ultrastructural study into the effects of pentobarbitone on synaptic organizationBrain Research, 1978